|
1
|
Riihimäki M, Hemminki A, Sundquist J and
Hemminki K: Patterns of metastasis in colon and rectal cancer. Sci
Rep. 6:297652016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Walasek T, Reinfuss M, Kurzynski M, Pluta
E, Patla A, Mituś JW and Sas-Korczyńska B: Brain metastasis from
colorectal carcinoma. Clinical picture, treatment and prognosis.
Oncol Radiother. 2:11–16. 2018.
|
|
3
|
Müller S, Köhler F, Hendricks A, Kastner
C, Börner K, Diers J, Lock JF, Petritsch B, Germer CT and Wiegering
A: Brain metastases from colorectal cancer: A systematic review of
the literature and meta-analysis to establish a guideline for daily
treatment. Cancers (Basel). 13:9002021. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Imaizumi J, Shida D, Narita Y, Miyakita Y,
Tanabe T, Takashima A, Boku N, Igaki H, Itami J and Kanemitsu Y:
Prognostic factors of brain metastases from colorectal cancer. BMC
Cancer. 19:7552019. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Benson AB, Venook AP, Al-Hawary MM, Azad
N, Chen YJ, Ciombor KK, Cohen S, Cooper HS, Deming D,
Garrido-Laguna I, et al: Rectal cancer, version 2.2022, NCCN
clinical practice guidelines in oncology. J Natl Compr Canc Netw.
20:1139–1167. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Yoshino T, Cervantes A, Bando H,
Martinelli E, Oki E, Xu RH, Mulansari NA, Govind Babu K, Lee MA,
Tan CK, et al: Pan-Asian adapted ESMO clinical practice guidelines
for the diagnosis, treatment and follow-up of patients with
metastatic colorectal cancer. ESMO Open. 8:1015582023. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Shindorf ML, Jafferji MS and Goff SL:
Incidence of asymptomatic brain metastases in metastatic colorectal
cancer. Clin Colorectal Cancer. 19:263–269. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ko FC, Liu JM, Chen WS, Chiang JK, Lin TC
and Lin JK: Risk and patterns of brain metastases in colorectal
cancer: 27-Year experience. Dis Colon Rectum. 42:1467–1471. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Falcone A, Ricci S, Brunetti I, Pfanner E,
Allegrini G, Barbara C, Crinò L, Benedetti G, Evangelista W,
Fanchini L, et al: Phase III trial of infusional fluorouracil,
leucovorin, oxaliplatin, and irinotecan (FOLFOXIRI) compared with
infusional fluorouracil, leucovorin, and irinotecan (FOLFIRI) as
first-line treatment for metastatic colorectal cancer: The gruppo
oncologico nord ovest. J Clin Oncol. 25:1670–1676. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Heinemann V, von Weikersthal LF, Decker T,
Kiani A, Kaiser F, Al-Batran SE, Heintges T, Lerchenmüller C, Kahl
C, Seipelt G, et al: FOLFIRI plus cetuximab or bevacizumab for
advanced colorectal cancer: Final survival and per-protocol
analysis of FIRE-3, a randomised clinical trial. Br J Cancer.
124:587–594. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kazama K, Shiozawa M, Numata M, Sugano N,
Sato S, Uchiyama M, Sato M, Aoyama T, Tamagawa H, Oshima T, et al:
Comparison of safety and efficacy of fluorouracil + oxaliplatin +
irinotecan (FOLFOXIRI) and modified FOLFOXIRI with bevacizumab for
metastatic colorectal cancer: Data from clinical practice. Int J
Colorectal Dis. 37:337–348. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yuan M, Wang Z, Zhao Y, Feng T, Lv W and
Zhong H: Cetuximab can be an effective and low-toxicity maintenance
treatment drug in patients with metastatic colorectal cancer: A
real-world study of Zhejiang cancer hospital. Front Pharmacol.
12:6320762021. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Luo HY, Li YH, Wang W, Wang ZQ, Yuan X, Ma
D, Wang FH, Zhang DS, Lin DR, Lin YC, et al: Single-agent
capecitabine as maintenance therapy after induction of XELOX (or
FOLFOX) in first-line treatment of metastatic colorectal cancer:
Randomized clinical trial of efficacy and safety. Ann Oncol.
27:1074–1081. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Vogelbaum MA, Brown PD, Messersmith H,
Brastianos PK, Burri S, Cahill D, Dunn IF, Gaspar LE, Gatson NTN,
Gondi V, et al: Treatment for brain metastases: ASCO-SNO-ASTRO
guideline. J Clin Oncol. 40:492–516. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Damiens K, Ayoub JPM, Lemieux B, Aubin F,
Saliba W, Campeau MP and Tehfe M: Clinical features and course of
brain metastases in colorectal cancer: An experience from a single
institution. Curr Oncol. 19:254–258. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Koo T, Kim K, Park HJ, Han SW, Kim TY,
Jeong SY, Park KJ and Chie EK: Prognostic factors for survival in
colorectal cancer patients with brain metastases undergoing whole
brain radiotherapy: Multicenter retrospective study. Sci Rep.
10:43402020. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ascha MS, Wang JF, Kumthekar P, Sloan AE,
Kruchko C and Barnholtz-Sloan JS: Bevacizumab for the treatment of
non-small cell lung cancer patients with synchronous brain
metastases. Sci Rep. 9:177922019. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Berghoff AS, Breckwoldt MO, Riedemann L,
Karimian-Jazi K, Loew S, Schlieter F, Furtner J, Cinci M, Thomas M,
Strowitzki MJ, et al: Bevacizumab-based treatment as salvage
therapy in patients with recurrent symptomatic brain metastases.
Neurooncol Adv 2. vdaa0382020.PubMed/NCBI
|
|
19
|
Chacko AM, Li C, Pryma DA, Brem S, Coukos
G and Muzykantov V: Targeted delivery of antibody-based therapeutic
and imaging agents to CNS tumors: Crossing the blood-brain barrier
divide. Expert Opin Drug Deliv. 10:907–926. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Finkelmeier F, You SJ, Waidmann O, Wolff
R, Zeuzem S, Bähr O and Trojan J: Bevacizumab in combination with
chemotherapy for colorectal brain metastasis. J Gastrointest
Cancer. 47:82–88. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Li W, Wang T, Zhu Y, Yu H, Ma L, Ding Y,
Hong G and Lei D: Brain metastasis from colorectal cancer:
Treatment, survival, and prognosis. Medicine (Baltimore).
101:e302732022. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Chahine G, Ibrahim T, Felefly T,
El-Ahmadie A, Freiha P, El-Khoury L, Khalife-Saleh N and Saleh K:
Colorectal cancer and brain metastases: An aggressive disease with
a different response to treatment. Tumori J. 105:427–433. 2019.
View Article : Google Scholar : PubMed/NCBI
|
